Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 183 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Aortic Stenosis Phase2 Austria
Belgium
Canada
Czechia
Denmark
France
Germany
Israel
Italy
Netherlands
Portugal
Spain
Switzerland
United Kingdom
United States
View All

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis Phase3 Argentina
Brazil
Bulgaria
Canada
China
Croatia
Estonia
France
Greece
India
Italy
Japan
Mexico
Poland
Portugal
Puerto Rico
Romania
Slovakia
Slovenia
South Africa
Spain
Sweden
Turkey (Türkiye)
United Kingdom
United States
View All

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

Prostate Cancer Phase2 Japan

Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma

Newly Diagnosed and Recurrent Glioblastoma Phase1 France
Germany
Israel
Italy
Portugal
Spain
United Kingdom
United States
View All

Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer

Metastatic Castration Resistant Prostate Cancer Germany

A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China

Chronic Spontaneous Urticaria China

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

C3G Phase3 Brazil
Canada
China
France
Germany
Greece
India
Israel
Italy
Japan
Netherlands
Spain
Switzerland
Turkey (Türkiye)
United Kingdom
United States
View All

Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world

Breast Cancer India

A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis

Multiple Sclerosis Germany

Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)

Systemic Lupus Erythematosus Phase3 Brazil
Bulgaria
Canada
China
Colombia
Czechia
Guatemala
Hungary
Israel
Japan
Poland
Portugal
Singapore
Slovakia
South Africa
Spain
Thailand
Turkey (Türkiye)
United States
View All